MELA Sciences Inc. (MELA) announced Monday morning that it received an approvable letter from the FDA for MelaFind.
MELA Sciences Inc. gapped open sharply higher Monday, but traded in a range for the majority of the session. Shares finished up by 1.75 at $4.93 on strong volume. The stock broke out of a 3-week range and set a 10-month high.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.